Andera Partners Diversified Active

Location: Paris, France

CIK: 0001757283 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 11, 2026

Total Value: $177M (100.0% shares, 0.0% debt)

Holdings (7)

KMTS KESTRA MED TECHNOLOGIES LTD 30.4%

Value $53.72M Shares 2,695,192 Est. Cost $25.72 Unrealized -2.1%

EVMN EVOMMUNE INC 24.7%

Value $43.62M Shares 1,897,362 Est. Cost $18.78 Unrealized +17.1%

MLYS MINERALYS THERAPEUTICS INC 24.4%

Value $43.13M Shares 1,591,917 Est. Cost $40.10 Unrealized -21.8%

AGMB AGOMAB THERAPEUTICS NV 9.1%

Value $16.14M Shares 1,538,702 Est. Cost $10.49 Unrealized —

IVA INVENTIVA SA 5.7%

Value $10.09M Shares 1,818,181 Est. Cost $4.65 Unrealized —

ABVX ABIVAX SA 4.9%

Value $8.699M Shares 78,125 Est. Cost $134.85 Unrealized —

NYXH NYXOAH S A 0.9%

Value $1.524M Shares 522,057 Est. Cost $4.75 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
KMTS	KESTRA MED TECHNOLOGIES LTD	2,695,192	$53.72M	30.4%	$25.72	-2.1%	SHS	G52441105
EVMN	EVOMMUNE INC	1,897,362	$43.62M	24.7%	$18.78	+17.1%	COM SHS	30054Y107
MLYS	MINERALYS THERAPEUTICS INC	1,591,917	$43.13M	24.4%	$40.10	-21.8%	COM	603170101
AGMB	AGOMAB THERAPEUTICS NV	1,538,702	$16.14M	9.1%	$10.49	—	SPONSORED ADS	00860C102
IVA	INVENTIVA SA	1,818,181	$10.09M	5.7%	$4.65	—	ADS	46124U107
ABVX	ABIVAX SA	78,125	$8.699M	4.9%	$134.85	—	SPONSORED ADS	00370M103
NYXH	NYXOAH S A	522,057	$1.524M	0.9%	$4.75	0.0%	SHS	B6S7WD106